Skip to main content
. 2019 Mar 27;10:236. doi: 10.3389/fphar.2019.00236

Figure 3.

Figure 3

The relationship between TRIB3 (251, A > G) genetic polymorphism and the hypotensive effects of α,β-ADRs monotherapy in EH patients. Panels (A–C) respectively depicts that BP- changes from baseline in EH patients carrying the TRIB3 (251, A > G) AA and AG/GG genotypes after treatment with α-ADR, β-ADR and α, β-ADRs for 6 weeks. P-value were adjusted for baseline age, BMI, gender, SBP, DBP, total cholesterol, heart rate, triglyceride, HDL, LDL, FBG and other biochemical factors appropriately. Error bar indicated 95% confidence interval.